New drug delivery could significantly improve treatment outcomes for localised prostate cancer
The research team at Queen's has developed a nanomedicine that could offer a more effective approach to radiotherapy
The research team at Queen's has developed a nanomedicine that could offer a more effective approach to radiotherapy
Researchers will help by testing the concrete which could revolutionize the concrete industry
200 x 20 µl reactions, 2 ml (2 x 1 ml) 2x supermix, contains Sso7d fusion polymerase in an advanced buffer formulation
500 x 20 µl reactions, 5 ml (1 x 5 ml) 2x supermix, contains Sso7d fusion polymerase in an advanced buffer formulation
Dr. Erwin Berthier discusses how remote capillary blood microsampling prioritizes patient experiences while maintaining clinical grade sample quality
Learn why antibodies are excellent clinical biomarkers – and the key technology you need to profile them
Dr. Sarah Kingston, Assistant Professor of Oceanography and Chief Scientist for Marine Biodiversity and Conservation at Sea Education Association, discusses the use of UV-Vis spectroscopy in her research and the future of molecular marine research
Discover the lab equipment enabling a new era of cancer research
Learn how a team of researchers at the Leibniz-Institut für Analytische Wissenschaften (ISAS) is developing scalable, AI-based biomedical image analysis algorithms to simplify the analysis of large image datasets
Discover insights on topics from cell line development and cancer research, to preparative HPLC and COVID-19 testing
New thinking around Bayes’ theorem, sepsis biomarkers, and additive diagnostic value could help unlock tests that improve patient care, even when they fall short of perfection
Researchers harness next-generation detectors to capture magnetic dynamics in microseconds
Miniaturization and automated liquid handling transform NGS workflows for precious sample processing
The first enzymatic solution for complete removal of chromatin at physiological salt conditions and its effect on down stream processing
Experts from Xbrane Biopharma discuss the biosimilar development process and how bioassays are the driving force behind reduced cost and accelerated timelines